Acrivon Therapeutics annual free cash flow
2021
2022
2023
2024
2025
Acrivon Therapeutics Free Cash Flow (FCF) History (ACRV)
Acrivon Therapeutics reported −$65.3M in free cash flow for fiscal 2025, an increase of $3.1M from the previous fiscal year.
View full Acrivon Therapeutics company overviewAcrivon Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$65.3M | $3.1M | — | — |
| 2024 | 2024-12-31 | −$68.4M | −$24.5M | — | — |
| 2023 | 2023-12-31 | −$43.9M | −$11.6M | — | — |
| 2022 | 2022-12-31 | −$32.3M | −$18.1M | — | — |
| 2021 | 2021-12-31 | −$14.2M | — | — | — |
Acrivon Therapeutics quarterly free cash flow
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$14.9M | $2.2M | — | — |
| Q1 2026 | 2026-03-31 | −$20.6M | −$959,000 | — | — |
| Q4 2025 | 2025-12-31 | −$15.5M | $2.7M | — | — |
| Q3 2025 | 2025-09-30 | −$13.2M | $5.1M | — | — |
| Q2 2025 | 2025-06-30 | −$17.1M | −$3.1M | — | — |
| Q1 2025 | 2025-03-31 | −$19.6M | −$1.7M | — | — |
| Q4 2024 | 2024-12-31 | −$18.2M | −$4.7M | — | — |
| Q3 2024 | 2024-09-30 | −$18.3M | −$8.5M | — | — |
| Q2 2024 | 2024-06-30 | −$14.0M | −$4.8M | — | — |
| Q1 2024 | 2024-03-31 | −$17.9M | −$6.5M | — | — |
| Q4 2023 | 2023-12-31 | −$13.5M | −$3.9M | — | — |
| Q3 2023 | 2023-09-30 | −$9.8M | −$2.9M | — | — |
| Q2 2023 | 2023-06-30 | −$9.2M | −$2.3M | — | — |
| Q1 2023 | 2023-03-31 | −$11.4M | −$2.5M | — | — |
| Q4 2022 | 2022-12-31 | −$9.6M | — | — | — |
| Q3 2022 | 2022-09-30 | −$6.9M | — | — | — |
| Q2 2022 | 2022-06-30 | −$6.9M | — | — | — |
| Q1 2022 | 2022-03-31 | −$8.8M | — | — | — |
Acrivon Therapeutics free cash flow growth trends
Acrivon Therapeutics's latest reported quarter, Q2 2026, generated −$14.9M in free cash flow, an increase of $2.2M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Acrivon Therapeutics filings at SEC.gov ↗